XML 176 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Noncontrol-ling interest
Beginning Balance (in shares) at Dec. 31, 2017     31,476,428          
Beginning Balance at Dec. 31, 2017 $ 533,759   $ 3,148 $ 1,410 $ 510,975   $ (24,023) $ 42,249
Beginning Balance (Topic 606) at Dec. 31, 2017   $ (8,714)       $ (8,714)    
Beginning Balance (ASC 340-40) at Dec. 31, 2017   $ (1,446)       $ (1,446)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to Ebix, Inc. 93,139       93,139      
Net loss attributable to noncontrolling interest (58)             (58)
Foreign currency translation adjustments (39,354)           (39,354)  
Exercise of stock options (in shares)     27,999          
Exercise of stock options 439   $ 3 436        
Repurchase and retirement of common stock (in shares)     (996,773)          
Repurchase and retirement of common stock (49,620)   $ (100)   (49,520)      
Deferred compensation and amortization related to options and restricted stock 2,811     2,811        
Vesting of restricted stock (in shares)     68,946          
Vesting of restricted stock 0   $ 6 (6)        
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested (in shares)     (8,875)          
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested (467)     (467)        
Noncontrolling interest 23,264     (787)       24,051
Common stock dividends paid (9,316)       (9,316)      
Ending Balance (in shares) at Dec. 31, 2018     30,567,725          
Ending Balance at Dec. 31, 2018 544,437   $ 3,057 3,397 535,118   (63,377) 66,242
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to Ebix, Inc. 96,720       96,720      
Net loss attributable to noncontrolling interest (6,149)             (6,149)
Foreign currency translation adjustments (15,021)           (15,021)  
Repurchase and retirement of common stock (in shares)     (95,000)          
Repurchase and retirement of common stock (4,152)   $ (10)   (4,142)      
Deferred compensation and amortization related to options and restricted stock 3,397     3,397        
Vesting of restricted stock (in shares)     24,107          
Vesting of restricted stock 0   $ 2 (2)        
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested (in shares)     (4,788)          
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested (230)     (230)        
Noncontrolling interest (10,364)     398       (10,762)
Common stock dividends paid (9,193)       (9,193)      
Ending Balance (in shares) at Dec. 31, 2019     30,492,044          
Ending Balance at Dec. 31, 2019 599,445   $ 3,049 6,960 618,503   (78,398) 49,331
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to Ebix, Inc. 92,377       92,377      
Net loss attributable to noncontrolling interest (3,550)             (3,550)
Foreign currency translation adjustments (23,105)           (23,105)  
Exercise of stock options (in shares)     30,000          
Exercise of stock options 636   $ 3 633        
Deferred compensation and amortization related to options and restricted stock 4,792     4,792        
Vesting of restricted stock (in shares)     68,504          
Vesting of restricted stock 0   $ 7 (7)        
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested (in shares)     (75,214)          
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested (2,589)   $ (7) (1,253) (1,329)      
Noncontrolling interest 1,343             1,343
Common stock dividends paid (9,245)       (9,245)      
Ending Balance (in shares) at Dec. 31, 2020     30,515,334          
Ending Balance at Dec. 31, 2020 $ 660,104   $ 3,052 $ 11,126 $ 700,304   $ (101,503) $ 47,125